<DOC>
	<DOCNO>NCT00855738</DOCNO>
	<brief_summary>Assessment efficacy daily clinical condition new antiepileptic drug ( AEDs ) gabapentin , lamotrigine , levetiracetam , oxcarbazepine , pregabalin , tiagabine topiramate , use first-choice combination therapy ( bitherapy ) patient focal epilepsy .</brief_summary>
	<brief_title>A Prospective , Observational Study On The Effectiveness Of New Antiepileptic Drugs As First Bitherapy In The Daily Clinical Practice</brief_title>
	<detailed_description />
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Epilepsies , Partial</mesh_term>
	<mesh_term>Lamotrigine</mesh_term>
	<mesh_term>Zonisamide</mesh_term>
	<mesh_term>Etiracetam</mesh_term>
	<mesh_term>Topiramate</mesh_term>
	<mesh_term>Gabapentin</mesh_term>
	<mesh_term>Tiagabine</mesh_term>
	<mesh_term>Anticonvulsants</mesh_term>
	<mesh_term>Pregabalin</mesh_term>
	<criteria>Aged 18 year old . Diagnosis focal epilepsy . Previous failure one AEDs use monotherapy . Background treatment antiepileptic drug . The investigator consider patient must start treatment seven new AEDs combination therapy : lamotrigine , levetiracetam , gabapentin , oxcarbazepine , pregabalin , tiagabine and/or topiramate . History seizures patient past 3 month . The patient legal guardian must able understand characteristic study fill seizure diary . Written informed consent . Inability comply study requirement . Diagnosis generalize epilepsy inability establish focal generalize . Presence serious uncontrolled systemic disease , serious psychiatric disease progressive neurological disease . History alcoholism , drug addiction , abuse medicine past two year . Psychogenic seizure two year prior inclusion study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>epilepsy antiepileptic biotherapy</keyword>
</DOC>